Trial-related discrimination in HIV vaccine clinical trials.
about
Impact of HIV vaccination on laboratory diagnosis: case reportsHIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physiciansHuman immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodiesYouth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania.HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.Exploring decision-making of HIV-infected Hispanics and African Americans participating in clinical trialsExperiences of social harm and changes in sexual practices among volunteers who had completed a phase I/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, TanzaniaSocio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.What should South African HIV vaccine trials do about social harms?Issues in women's participation in a phase III community HIV vaccine trial in ThailandSocial and behavioral science in HIV vaccine trials: a gap assessment of the literature.Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania.Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection.HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.
P2860
Q24803552-22AB9BB9-AECE-4113-9867-92C5D48AEF09Q28082836-82B30348-F5B0-48DC-A570-A752A2504E11Q33233776-75F8762E-B3CE-494A-8BC0-017EDCD5DAE3Q34030735-679D0720-9701-4DD4-968D-45ADD5A507B1Q34056675-C473BAEF-9C59-426A-9F11-CFE924FB2DC1Q34313611-ABCBA015-C66B-4289-BC17-D61F90A62637Q34990295-F9921DEE-E2EE-4B6F-8E51-EBCA91E98421Q35113217-110D4E54-028B-44B4-B958-867C5F3B6110Q35698044-D2CA9F9D-A4EC-4868-97C6-1265A1EA2361Q36853358-46C05731-7866-42FD-BB5A-89ECF665BF79Q37024050-3C721314-0B92-421E-9E37-23ADF0CCFBECQ37259757-DD3C84CC-6A0E-472B-A020-FFC761FB6D57Q37386288-F95B0AD5-B258-4E0E-A724-61D4A1263AAAQ37427237-87CDE1C6-3A6A-4928-93E0-C19ACA147BB7Q37643303-46082287-07DA-41E3-AA9A-C14AD707B180Q39919006-2A5A648A-D866-4F31-861E-8C0EC8A50AA8Q45143982-62C122C2-1A90-40E6-8814-4CBC3A4D7F91
P2860
Trial-related discrimination in HIV vaccine clinical trials.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Trial-related discrimination in HIV vaccine clinical trials.
@en
Trial-related discrimination in HIV vaccine clinical trials.
@nl
type
label
Trial-related discrimination in HIV vaccine clinical trials.
@en
Trial-related discrimination in HIV vaccine clinical trials.
@nl
prefLabel
Trial-related discrimination in HIV vaccine clinical trials.
@en
Trial-related discrimination in HIV vaccine clinical trials.
@nl
P2093
P1476
Trial-related discrimination in HIV vaccine clinical trials
@en
P2093
P304
P356
10.1089/088922201750236942
P50
P577
2001-05-01T00:00:00Z